Similarly, survival probability in hepatocellular carcinoma was reliably predicted by a glioma prediction model (ACSL3, ACSL6, ACACA, G6PD, SLC1A5, SLC7A11 and VDAC2) (48) and by a risk model with a strong overlap with the genes in the glioma models (G6PD, HMOX1, LOX, SLC7A11, STMN1/Stathmin 1) (49). The gene discussed is LOX; the disease is central nervous system cancer.